ResearcherPhenomenome Discoveries (Canada)No recent work listed

Shawn A. Ritchie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2061-4937; OpenAlex author ID A5112246530. Sources: OpenAlex.

Their work

Papers: 3 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper

Papers 3

Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study. First author DOI 10.1097/mpa.0000000000000680 ↗
Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9. Co-author DOI 10.3748/wjg.v21.i21.6604 ↗
Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. Co-author DOI 10.1186/1471-2407-13-416 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Morito Monden · 2 shared papers, 2013–2016 · strength 0.08
- Paper Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study. DOI 10.1097/mpa.0000000000000680 ↗
- Paper Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. DOI 10.1186/1471-2407-13-416 ↗
Yuichiro Doki · 2 shared papers, 2013–2016 · strength 0.08
- Paper Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study. DOI 10.1097/mpa.0000000000000680 ↗
- Paper Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. DOI 10.1186/1471-2407-13-416 ↗
Hidetoshi Eguchi · 2 shared papers, 2013–2016 · strength 0.08
- Paper Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study. DOI 10.1097/mpa.0000000000000680 ↗
- Paper Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. DOI 10.1186/1471-2407-13-416 ↗
Hirofumi Akita · 2 shared papers, 2013–2016 · strength 0.08
- Paper Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study. DOI 10.1097/mpa.0000000000000680 ↗
- Paper Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. DOI 10.1186/1471-2407-13-416 ↗
Hiroaki Nagano · 2 shared papers, 2013–2016 · strength 0.08
- Paper Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study. DOI 10.1097/mpa.0000000000000680 ↗
- Paper Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. DOI 10.1186/1471-2407-13-416 ↗
Ichiro Takemasa · 2 shared papers, 2013–2016 · strength 0.08
- Paper Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study. DOI 10.1097/mpa.0000000000000680 ↗
- Paper Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. DOI 10.1186/1471-2407-13-416 ↗
Dayan B. Goodenowe · 2 shared papers, 2013–2016 · strength 0.08
- Paper Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study. DOI 10.1097/mpa.0000000000000680 ↗
- Paper Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. DOI 10.1186/1471-2407-13-416 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.